ALKS Alkermes plc

Price (delayed)

$29.71

Market cap

$4.86B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.38

Enterprise value

$4.99B

Alkermes plc is a biopharmaceutical company that focuses on central nervous system diseases such as such as schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 by ...

Highlights
The revenue has grown by 15% YoY and by 2.3% from the previous quarter
Alkermes's gross profit has increased by 13% YoY
The EPS is up by 37% year-on-year but it has declined by 27% since the previous quarter
Alkermes's net income has increased by 35% YoY but it has decreased by 28% from the previous quarter
ALKS's quick ratio is down by 21% year-on-year and by 7% since the previous quarter

Key stats

What are the main financial stats of ALKS
Market
Shares outstanding
163.43M
Market cap
$4.86B
Enterprise value
$4.99B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.47
Price to sales (P/S)
4.02
EV/EBIT
N/A
EV/EBITDA
225.16
EV/Sales
4.15
Earnings
Revenue
$1.2B
EBIT
-$56.05M
EBITDA
$22.15M
Free cash flow
$140.83M
Per share
EPS
-$0.38
Free cash flow per share
$0.87
Book value per share
$6.64
Revenue per share
$7.39
TBVPS
$11.2
Balance sheet
Total assets
$1.98B
Total liabilities
$902.46M
Debt
$415.33M
Equity
$1.08B
Working capital
$552.47M
Liquidity
Debt to equity
0.39
Current ratio
2.19
Quick ratio
1.68
Net debt/EBITDA
5.99
Margins
EBITDA margin
1.8%
Gross margin
82.4%
Net margin
-5.1%
Operating margin
-3.3%
Efficiency
Return on assets
-3.1%
Return on equity
-5.6%
Return on invested capital
-3.8%
Return on capital employed
-3.7%
Return on sales
-4.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALKS stock price

How has the Alkermes stock price performed over time
Intraday
0.51%
1 week
5.99%
1 month
4.8%
1 year
21.17%
YTD
27.73%
QTD
12.92%

Financial performance

How have Alkermes's revenue and profit performed over time
Revenue
$1.2B
Gross profit
$989.34M
Operating income
-$39.44M
Net income
-$61.65M
Gross margin
82.4%
Net margin
-5.1%
The company's operating margin has surged by 63% YoY but it fell by 32% QoQ
Alkermes's operating income has soared by 57% YoY but it has decreased by 35% from the previous quarter
The net margin has grown by 44% YoY but it has contracted by 24% from the previous quarter
Alkermes's net income has increased by 35% YoY but it has decreased by 28% from the previous quarter

Growth

What is Alkermes's growth rate over time

Valuation

What is Alkermes stock price valuation
P/E
N/A
P/B
4.47
P/S
4.02
EV/EBIT
N/A
EV/EBITDA
225.16
EV/Sales
4.15
The EPS is up by 37% year-on-year but it has declined by 27% since the previous quarter
The P/B is 15% higher than the last 4 quarters average of 3.9 and 4% higher than the 5-year quarterly average of 4.3
The company's equity fell by 3.3% QoQ but it rose by 2.3% YoY
ALKS's P/S is 18% below its 5-year quarterly average of 4.9 but 9% above its last 4 quarters average of 3.7
The revenue has grown by 15% YoY and by 2.3% from the previous quarter

Efficiency

How efficient is Alkermes business performance
The ROIC has plunged by 100% from the previous quarter but it has increased by 24% YoY
The ROS has dropped by 96% since the previous quarter but it is up by 34% year-on-year
The ROA rose by 38% YoY but it fell by 24% QoQ
The return on equity has increased by 37% year-on-year but it has declined by 27% since the previous quarter

Dividends

What is ALKS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALKS.

Financial health

How did Alkermes financials performed over time
Alkermes's total assets is 119% higher than its total liabilities
ALKS's quick ratio is down by 21% year-on-year and by 7% since the previous quarter
The current ratio has contracted by 20% YoY and by 2.7% from the previous quarter
The debt is 61% less than the equity
The debt to equity is up by 5% from the previous quarter but it is down by 4.9% YoY
The company's equity fell by 3.3% QoQ but it rose by 2.3% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.